SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : A Biotech Bonanza!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Giuseppe Scalamogna who wrote (1)9/18/1997 9:48:00 PM
From: LLCF   of 64
 
This is a great idea!! Hurray! I've been hearing a great deal on the sector by some very savy people for quite some time...basically what your saying in your prologue, that there are many companies that are finally getting their science into mid and late stages that are trading for a fraction of what it cost to get them there and a fraction of their value. One concern I have is the pace...one per week although for indepth discussion may actually be very fast, with what I think the sector will be doing this fall may leave us wanting. Maybe we could start a bulliten board with ideas as well?? With categories (ie. company A has 2 approved drugs with annual revenues of X expected to grow at Y....1 drug in phase 3 with potential sales of x, 3 drugs in phase 2 etc., etc, etc,??? I dont know...just an idea...I would like to hear some ideas for core positions to get on board! One thing I did last week was buy "HQH" on the big board...Hambricht and Quist closed end medical fund with 40% biotech...traded at 17% discount at the time. I also own CHIR and ISIP, as well as ENZN.

DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext